British scientists are developing a gene editing technique that could enable cancer cells to be destroyed by the immune system, it has been announced.
The technique involves the genetic alteration of T-cells.
It has so far been tested successfully on laboratory mice.
Scientists have removed a "switch" called PD1 from T cells. The switch sends the cells to sleep and is exploited by some kinds of cancer to avoid the immune system.
Some immunotherapy drugs tackle the same problem – but have caused severe side-effects because they act on the whole immune system.
The findings have been reported in the journal Cancer Research.
Researcher Dr Sergio Quezada, of University College London’s Cancer Institute, said: “This is an exciting discovery and means we may have a way to get around cancer’s defences while only targeting the immune cells that recognise the cancer.
“While drugs that block PD-1 do show promise, this method only knocks out PD-1 on the T cells that can find the tumour which could mean fewer side effects for patients.”
Professor Peter Johnson, chief clinician at Cancer Research UK, said: “We know that some cancers can switch off the cells of our immune system, and this interesting laboratory research suggests a new way that we might be able to get around the problem, although this is still some way away from use in the clinic."
Menger et al., TALEN-mediated inactivation of PD-1 in tumor-reactive lymphocytes promotes intratumoral T cell persistence and rejection of established tumors. Cancer Research 15 April 2016

Leave a Reply